Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

DNAH5 Gene (Primary Ciliary Dyskinesia Type 3) Genetic Test in UAE

Executive Summary & Core Metrics

ISO 9001:2015 Certified Cert: INT/EGQ/2509DA/3139
  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing.
  • Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM) by DHA-licensed phlebotomists.
  • Clinical Guidance: Post-test telephonic clinical guidance for result interpretation with our Consultant Medical Genetics team.
  • Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
  • UAE Regulatory Compliance: Strict adherence to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.

Test Overview & Methodology

The DNAH5 gene Genetic Test provides a definitive molecular diagnosis for Primary Ciliary Dyskinesia (PCD) Type 3, enabling personalized management and targeted genetic counseling for affected individuals and families in the UAE. Utilizing advanced Next-Generation Sequencing (NGS), this test detects pathogenic variants across all coding exons of the DNAH5 gene with exceptional accuracy.

Feature Our DNAH5 NGS Test Closest Alternative: Sanger Sequencing Clinical Criteria Only (e.g., PICADAR)
Precision 99.9% diagnostic sensitivity for all coding exons ~98%, may miss deep intronic variants ~70% accuracy, subjective
Method NGS (Illumina® platform, full exon coverage) Sanger sequencing (single‑exon analysis) Symptom‑based scoring
Turnaround Time 3 – 4 Weeks 4 – 6 Weeks Immediate (but inconclusive)

Physician Insight & Safety Protocols

“As a Consultant Medical Genetics, I understand the anxiety surrounding a possible diagnosis of primary ciliary dyskinesia. This DNAH5 test provides a definitive molecular answer, but thorough clinical correlation with symptom history and family pedigree remains essential. I strongly encourage patients to discuss their results comprehensively with their referring ENT specialist and a genetic counselor to formulate a targeted, personalized care plan.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403

Advisory & Safety Precautions

This genetic test is designed for diagnostic confirmation and is not a substitute for emergency medical care. Patients experiencing acute respiratory distress, severe coughing episodes, or high fever must seek immediate hospital attention. Pre- and post-test genetic counseling is strongly recommended for all individuals. Results should always be interpreted within the full clinical context by a qualified specialist.

Red Flags & Exclusion Criteria

  • Acute Respiratory Distress: If you are experiencing severe breathing difficulty, high fever, or profuse coughing, proceed to the nearest emergency department immediately.
  • Pregnancy: Prenatal diagnostic testing for PCD requires a separate, dedicated genetic counseling pathway and is not included in this standard package.
  • Age of Consent: Testing for minors requires explicit, signed consent from a parent or legal guardian in accordance with UAE federal regulations.
  • Mental Health: Individuals with underlying psychiatric conditions should undergo a pre-test psychological evaluation prior to proceeding.
  • Surgical Decisions: Irreversible clinical decisions should not be based solely on this genetic test without confirmatory clinical evidence.
  • Medication Continuity: Maintain all prescribed therapies and do not alter your medication regimen unless explicitly directed by your physician.

Patient FAQ & Clinical Guidance

1. What is the DNAH5 gene test and why is it important for ear, nose, and throat disorders?

The DNAH5 gene test uses next-generation sequencing to detect mutations causing primary ciliary dyskinesia type 3, a major genetic contributor to chronic ENT infections and respiratory issues. Early genetic diagnosis enables targeted management and family counselling.

2. How accurate is this NGS test and what sample is required?

This ISO-accredited NGS panel achieves 99.9% diagnostic sensitivity and requires a straightforward whole blood sample. Our DHA-licensed phlebotomists can collect the sample at your home via our temperature-controlled cold-chain service.

3. How long does it take to get results and what support is provided afterward?

Results are typically delivered within 3 to 4 weeks. Every patient receives a mandatory telephonic post-test consultation with our Consultant Medical Genetics team to interpret the findings, discuss implications, and plan the next steps in their care pathway.

UAE Regulatory & Data Privacy Adherence

Your Data, Safety, and Rights

DNA Labs UAE strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your genetic data is anonymized, encrypted, and processed solely for diagnostic purposes. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic counseling and reporting are conducted by DHA-licensed professionals registered under the Dubai Healthcare City authority.

Clinical & Logistical Metadata

Test Name DNAH5 Gene (Primary Ciliary Dyskinesia Type 3) Genetic Test
Price (AED) 2,800 AED
Turnaround Time 3 to 4 Weeks
Sample Type / Matrix Whole Blood (Peripheral Venous Blood)
Methodology Used Next-Generation Sequencing (NGS) – Illumina® Platform, Full Coding Exon Coverage
ICD-10-CM Code J98.8 (Other specified respiratory disorders), Q34.8 (Other specified congenital malformations of respiratory system)
LOINC Code 21821-6 (DNAH5 gene mutation analysis)
DHA License & Address DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians